Favorable outcome of hematopoietic stem cell transplantation in late-onset Krabbe disease
Brain and Development · 2023
DOI: 10.1016/j.braindev.2023.04.001 ↗Kurz gefasst
Fallbericht in der Zeitschrift Brain and Development, 2023. Verfasst von Akihiko Mitsutake und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan; Department of Neurology, International University of Health and Welfare Mita…. Hauptthemen laut MEDLINE: Leukodystrophy, Globoid Cell, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Late-onset Krabbe disease is a disorder with autosomal recessive inheritance caused by a deficiency in galactocerebrosidase (GALC) activity. Its late-onset form usually shows slow disease progression with atypical symptoms including spastic paresis. The efficacy of hematopoietic stem cell transplantation (HSCT) in late-onset Krabbe disease has not been fully established. CASE REPORT: We describe the case of a patient with late-onset Krabbe disease showing progressive spastic paraparesis. At the age of 18, one and a half years after the development of symptoms, the patient underwent HSCT. After HSCT, the patient's GALC activity returned to a normal level and the lesions in the brain and spinal cord became faint on images. Over two and a half years after the HSCT, the patient's gait remained spastic, however, an improvement in gait speed and modified Rankin Scale score was observed. No severe adverse events occurred during this period. CONCLUSION: Our experience reported herein provides additional evidence for a favorable course in HSCT conducted in the early course of late-onset Krabbe disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan; Department of Neurology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
- Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan. Electronic address: matsukawa1012@gmail.com.
- Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan; Department of Neurology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
- Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan; Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.
- Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan; Department of Precision Medicine Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Radiology, School of Medicine, Jichi Medical University, Tochigi, Japan.
Zitieren
APA
Mitsutake, A., Matsukawa, T., Iwata, A., Ishiura, H., Mitsui, J., Mori, H., Toya, T., Honda, A., Kurokawa, M., Sakai, N., Tsuji, S., & Toda, T. (2023). Favorable outcome of hematopoietic stem cell transplantation in late-onset Krabbe disease. Brain and Development. https://doi.org/10.1016/j.braindev.2023.04.001
Vancouver
Mitsutake A, Matsukawa T, Iwata A, Ishiura H, Mitsui J, Mori H, et al. Favorable outcome of hematopoietic stem cell transplantation in late-onset Krabbe disease. Brain and Development. 2023. doi:10.1016/j.braindev.2023.04.001
BibTeX
@article{Mitsutake2023,
author = {Mitsutake, Akihiko and Matsukawa, Takashi and Iwata, Atsushi and Ishiura, Hiroyuki and Mitsui, Jun and Mori, Harushi and Toya, Takashi and Honda, Akira and Kurokawa, Mineo and Sakai, Norio and Tsuji, Shoji and Toda, Tatsushi},
title = {Favorable outcome of hematopoietic stem cell transplantation in late-onset Krabbe disease},
journal = {Brain and Development},
year = {2023},
doi = {10.1016/j.braindev.2023.04.001}
}
EUVIMED